Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

PP290 Topic: AS03–Disaster Medicine/Trauma, Triage and Transport/Mass Critical Care/Pandemics/Medicine in War Zones/Other: CLINICAL CHARACTERISTICS AND HEALTH OUTCOMES FOR CHILDREN HOSPITALIZED WITH COVID-19

Appiah JA. et al, (2024), Pediatric Critical Care Medicine, 25

Cost-Effectiveness of Test-and-Treat Strategies to Reduce the Antibiotic Prescription Rate for Acute Febrile Illness in Primary Healthcare Clinics in Africa.

van Dorst PWM. et al, (2024), Appl Health Econ Health Policy, 22, 701 - 715

Impact of a package of point-of-care diagnostic tests, a clinical diagnostic algorithm and adherence training on antibiotic prescriptions for the management of non-severe acute febrile illness in primary health facilities during the COVID-19 pandemic in Burkina Faso.

Kiemde F. et al, (2024), BMC Infect Dis, 24

At-admission prediction of mortality and pulmonary embolism in an international cohort of hospitalised patients with COVID-19 using statistical and machine learning methods.

Mesinovic M. et al, (2024), Sci Rep, 14

An open-label, randomized, non-inferiority trial of the efficacy and safety of ciprofloxacin versus an aminoglycoside + ciprofloxacin in the treatment of bubonic plague (IMASOY): study protocol for a randomized control trial-an update to the published protocol.

Randremanana RV. et al, (2024), Trials, 25

Challenges in clinical diagnosis of Clade I Mpox: Highlighting the need for enhanced diagnostic approaches.

Bourner J. et al, (2024), PLoS Negl Trop Dis, 18

The facilitators of and barriers to antimicrobial use and misuse in Lalitpur, Nepal: a qualitative study.

Udas S. et al, (2024), BMC Public Health, 24

Interpretations of Studies on SARS-CoV-2 Vaccination and Post-acute COVID-19 Sequelae.

Gonçalves BP. et al, (2024), Epidemiology, 35, 368 - 371

Diagnostic tests for human Schistosoma mansoni and Schistosoma haematobium infection: a systematic review and meta-analysis.

Vaillant MT. et al, (2024), Lancet Microbe, 5, e366 - e378

Nipah Virus Therapeutics: A Systematic Review to Support Prioritisation for Clinical Trials

Chan XHS. et al, (2024)

Systematic Review of Scales for Measuring Infectious Disease-Related Stigma.

Paterson A. et al, (2024), Emerg Infect Dis, 30, 519 - 529

Event rates and incidence of post-COVID-19 condition in hospitalised SARS-CoV-2 positive children and young people and controls across different pandemic waves: exposure-stratified prospective cohort study in Moscow (StopCOVID).

Pazukhina E. et al, (2024), BMC Med, 22

Involving patients in drug development for Neglected Tropical Diseases (NTDs): A qualitative study exploring and incorporating preferences of patients with cutaneous leishmaniasis into Target Product Profile development

Castro MDM. et al, (2024), PLoS Neglected Tropical Diseases, 2024

Involving patients in drug development for Neglected Tropical Diseases (NTDs): A qualitative study exploring and incorporating preferences of patients with cutaneous leishmaniasis into Target Product Profile development.

Castro MDM. et al, (2024), PLoS Negl Trop Dis, 18

Nipah virus disease: what can we do to improve patient care?

Hassan MZ. et al, (2024), Lancet Infectious Diseases

Experiences and challenges with the new European Clinical Trials Regulation.

Patrick-Brown TDJH. et al, (2024), Trials, 25

Challenges in Clinical Diagnosis of Clade I Mpox: Highlighting the Need for Enhanced Diagnostic Approaches

Bourner J. et al, (2024)

Expanded Access Programme for the use of tecovirimat for the treatment of monkeypox infection: A study protocol for an Expanded Access Programme.

Bourner J. et al, (2024), PLoS One, 19

Mpox: The alarm went off. Have we gone back to sleep?

Olliaro P. et al, (2024), PLoS Negl Trop Dis, 18

Sex differences in post-acute neurological sequelae of SARS-CoV-2 and symptom resolution in adults after coronavirus disease 2019 hospitalization: an international multi-centre prospective observational study.

Cho S-M. et al, (2024), Brain Commun, 6

Load More

1
2
3
4
5

Include forthcoming?